Neogen Cash Beginning of Year vs Capital Expenditure Analysis
NEOG Stock | USD 15.46 0.46 3.07% |
Trend analysis of Neogen balance sheet accounts such as Total Current Liabilities of 175.7 M provides information on Neogen's total assets, liabilities, and equity, which is the actual value of Neogen to its prevalent stockholders. By breaking down trends over time using Neogen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Neogen |
About Neogen Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Neogen at a specified time, usually calculated after every quarter, six months, or one year. Neogen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Neogen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Neogen currently owns. An asset can also be divided into two categories, current and non-current.
Neogen Balance Sheet Chart
Neogen Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Neogen uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Neogen's Other Current Liabilities is most likely to increase significantly in the upcoming years. The Neogen's current Total Current Liabilities is estimated to increase to about 175.7 M, while Accumulated Other Comprehensive Income is forecasted to increase to (28.4 M). Add Fundamental
Total Assets
Total assets refers to the total amount of Neogen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Neogen books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Neogen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Neogen are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Neogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.At this time, Neogen's Selling General Administrative is most likely to increase significantly in the upcoming years. The Neogen's current Enterprise Value Multiple is estimated to increase to 113.83, while Tax Provision is projected to decrease to roughly 707.9 K.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 243.0M | 406.0M | 466.8M | 490.2M | Total Revenue | 527.2M | 822.4M | 945.8M | 993.1M |
Neogen fundamental ratios Correlations
Click cells to compare fundamentals
Neogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neogen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 797.2M | 920.2M | 992.9M | 4.6B | 5.2B | 5.5B | |
Other Current Liab | 22.8M | 25.0M | 36.3M | 60.9M | 70.0M | 73.5M | |
Total Current Liabilities | 48.5M | 53.6M | 77.8M | 145.5M | 167.3M | 175.7M | |
Total Stockholder Equity | 725.2M | 840.4M | 887.4M | 3.1B | 3.6B | 3.8B | |
Property Plant And Equipment Net | 78.7M | 100.5M | 110.6M | 198.7M | 228.6M | 240.0M | |
Net Debt | (342.6M) | (379.8M) | 605.6M | 736.8M | 663.1M | 696.2M | |
Retained Earnings | 478.7M | 539.6M | 587.9M | 565.0M | 649.8M | 682.3M | |
Cash | 343.7M | 381.1M | 381.1M | 163.2M | 187.7M | 197.1M | |
Non Current Assets Total | 259.8M | 328.7M | 366.1M | 4.0B | 4.6B | 4.8B | |
Non Currrent Assets Other | 2.2M | 2.0M | 2.2M | 15.2M | 17.5M | 15.5M | |
Cash And Short Term Investments | 343.7M | 381.1M | 381.1M | 245.6M | 282.4M | 296.5M | |
Net Receivables | 84.7M | 91.8M | 99.7M | 153.3M | 176.2M | 185.1M | |
Common Stock Shares Outstanding | 105.7M | 107.5M | 108.0M | 216.4M | 248.9M | 261.4M | |
Liabilities And Stockholders Equity | 797.2M | 920.2M | 992.9M | 4.6B | 5.2B | 5.5B | |
Non Current Liabilities Total | 23.5M | 26.2M | 27.7M | 1.3B | 1.5B | 1.5B | |
Inventory | 95.1M | 100.7M | 122.3M | 133.8M | 153.9M | 161.6M | |
Other Current Assets | 14.0M | 17.8M | 23.8M | 53.3M | 61.3M | 64.4M | |
Other Stockholder Equity | 257.7M | 295.0M | 310.0M | 2.6B | 3.0B | 3.1B | |
Total Liab | 72.0M | 79.8M | 105.6M | 1.4B | 1.6B | 1.7B | |
Property Plant And Equipment Gross | 80.6M | 102.9M | 215.5M | 318.9M | 366.7M | 385.0M | |
Total Current Assets | 537.4M | 591.5M | 626.8M | 585.9M | 673.8M | 707.5M | |
Accumulated Other Comprehensive Income | (19.7M) | (11.4M) | (27.8M) | (33.3M) | (29.9M) | (28.4M) | |
Intangible Assets | 66.6M | 92.3M | 107.5M | 1.6B | 1.8B | 1.9B | |
Accounts Payable | 25.7M | 23.9M | 34.6M | 76.7M | 88.2M | 92.6M | |
Common Stock Total Equity | 8.5M | 17.2M | 17.2M | 34.6M | 39.8M | 41.8M | |
Short Term Investments | 277.4M | 305.5M | 336.6M | 82.3M | 94.7M | 91.9M | |
Common Stock | 8.5M | 17.2M | 17.2M | 34.6M | 39.8M | 37.8M | |
Other Liab | 22.6M | 26.2M | 27.7M | 375.7M | 432.1M | 453.7M | |
Other Assets | 2.2M | 2.0M | 4.8B | 15.2M | 17.5M | 16.6M | |
Good Will | 181.1M | 228.3M | 255.5M | 3.8B | 4.3B | 4.6B | |
Property Plant Equipment | 78.7M | 100.5M | 110.6M | 198.7M | 228.6M | 240.0M | |
Net Tangible Assets | 599.6M | 612.1M | 887.4M | 3.1B | 3.6B | 3.8B | |
Retained Earnings Total Equity | 478.7M | 539.6M | 587.9M | 565.0M | 649.8M | 382.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
CEOs Directory Screen CEOs from public companies around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Neogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share 0.1 | Revenue Per Share 4.249 | Quarterly Revenue Growth (0) | Return On Assets 0.0119 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.